← Scroll for more →
Mirum Pharmaceuticals, Inc. (MIRM)
Pharmaceutical Preparations
Latest Price
$85.81
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
4.12
P/B Ratio
20.83
Valuation metrics
adjust assumptions →Base FCF: $32M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$53.42
35% downside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 7.68M | $899.0M | 11.86% | -- | 2026-06-30 |
| Jupiter Topco LLC | 5.91M | $691.0M | 9.13% | -- | 2026-06-30 |
| BlackRock, Inc. | 4.39M | $513.0M | 6.78% | +543.5K | 2026-06-30 |
| FMR LLC | 3.67M | $429.0M | 5.67% | +1.70M | 2026-06-30 |
| Price T Rowe Associates Inc | 2.66M | $310.0M | 4.10% | +938.2K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 2.38M | $278.0M | 3.67% | +944.9K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.25M | $263.0M | 3.48% | -160.7K | 2026-06-30 |
| State Street Corp | 2.17M | $254.0M | 3.35% | +226.4K | 2026-06-30 |
| William Blair Investment Management, LLC | 1.40M | $164.0M | 2.17% | +1.07M | 2026-06-30 |
| Geode Capital Management, LLC | 1.39M | $163.0M | 2.15% | +133.9K | 2026-06-30 |